Search results
Results from the WOW.Com Content Network
A medical professional can walk you through the pros, cons, and common side effects of tirzepatide and compounded tirzepatide to help you figure out if it’s the right option for you.
Tirzepatide is a gastric inhibitory polypeptide analog and GLP-1 receptor agonist. [10] The most common side effects include nausea, vomiting, diarrhea, decreased appetite, constipation, upper abdominal discomfort, and abdominal pain. [9] [13] [18]
GLP-1 drugs used for weight loss involve all kinds of side effects—good and not-so-good—that may or may not strike the average user. (Reminder that there are many of these meds now.
Tirzepatide is a GIP/GLP-1. ... That said, no medication is without side effects. The most common side effects of GLP-1 medications are gastrointestinal issues, including: Constipation.
GLP1 poly-agonist peptides [1] are a class of drugs that activate multiple peptide hormone receptors including the glucagon-like peptide-1 (GLP-1) receptor.These drugs are developed for the same indications as GLP-1 receptor agonists—especially obesity, type 2 diabetes, and non-alcoholic fatty liver disease.
[1] [2] In a Phase II trial, weight loss averaged -15.6 percent after 32 weeks, making CagriSema comparable in efficacy to tirzepatide. [3] [4] A future trial sponsored by Novo Nordisk is comparing tirzepatide and CagriSema head-to-head. [5] CagriSema entered Phase III clinical trials in 2023. [6]
A large study of more than 2 million people evaluated benefits and risks of GLP-1 agonists. The study showed that GLP-1 agonists reduced risk of substance use and psychotic disorders, seizures, neurocognitive disorders (including Alzheimer’s disease and dementia), coagulation disorders, cardiometabolic disorders, infectious illnesses and several respiratory conditions [5].
The injection itself was easy and fairly painless, and I didn’t have any immediate side effects. TBH, I only knew the medication was working because I slowly started losing weight. After about a ...